Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kairos Pharma, LTD. | 293,039 | reported | 08 Oct 2025 | tx 2+155,172 |
| GENELUX Corp | 40,000 | reported | 11 Sept 2023 | tx 3+43,600−1,297 |
| Newton Golf Company, Inc. | 36,000 | reported | 09 Sept 2024 | tx 1+36,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Oct 2025 | GRANT_AWARD | Kairos Pharma, LTD. | 152,672 | 0.00 USD | |
| 22 Nov 2024 | PURCHASE | Kairos Pharma, LTD. | 2,500 | 1.50 USD | |
| 09 Sept 2024 | GRANT_AWARD | Newton Golf Company, Inc. | 36,000 | 0.00 USD | deriv |
| 11 Sept 2023 | GRANT_AWARD | GENELUX Corp | 40,000 | 0.00 USD | deriv |
| 18 Aug 2023 | SALE | GENELUX Corp | 1,297 | 23.73 USD | |
| 17 Feb 2023 | GRANT_AWARD | GENELUX Corp | 3,600 | 0.00 USD |